X-group (possible homology)

825 Aerolysin family of pore-forming toxins

Ligands and drugs

428
Member domains
100
with ligand contacts (≤ 4 Å)
23.4% of members
85
with DrugDomain annotations
19.9% of members
39
with a DrugBank compound
9.1% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

12
Proteins with classified ligands
6
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds75.81.21×q = 0.65
Organic nitrogen compounds20.45.30×not tested
Organic oxygen compounds42.41.70×not tested
Benzenoids10.91.16×not tested
Organic acids and derivatives11.80.55×not tested
Homogeneous non-metal compounds12.60.39×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02900M6Palpha-D-mannose 6-phosphate2
DB03975MBOMercuribenzoic Acid2
DB00145GLYGlycine1
DB02676B3P2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol1

Most frequently bound compounds

PDB ligandNameDomains in contact
ZNmetalZINC ION14
P6GHEXAETHYLENE GLYCOL12
MRD(4R)-2-METHYLPENTANE-2,4-DIOL9
CAmetalCALCIUM ION7
MGmetalMAGNESIUM ION5
HGmetalMERCURY (II) ION4
NAmetalSODIUM ION4
CLCHLORIDE ION3
U1metalURANIUM ATOM3
B3P2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL2
M6P6-O-phosphono-alpha-D-mannopyranose2
MBOMERCURIBENZOIC ACID2
0SMTRIMETHYL-[2-[[(2S,3S)-2-(OCTADECANOYLAMINO)-3-OXIDANYL-BUTOXY]-OXIDANYL-PHOSPHORYL]OXYETHYL]AZANIUM1
AMGmethyl alpha-D-galactopyranoside1
GLYGLYCINE1
LUmetalLUTETIUM (III) ION1
NGA2-acetamido-2-deoxy-beta-D-galactopyranose1
PCPHOSPHOCHOLINE1
SMmetalSAMARIUM (III) ION1
UNXUNKNOWN ATOM OR ION1